Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Current Opinion in Genetics & Development|July 6, 2020
Nucleic acid therapeutics in neurodevelopmental diseaseAudrey M Winkelsas, Kenneth H FischbeckNeurobiology of Disease|July 30, 2022
Altered SYNJ2BP-mediated mitochondrial-ER contacts in motor neuron diseaseNaemeh Pourshafie, Ester Masati, Amber Lopez, et al.Journal of Molecular Neuroscience : MN|November 9, 2015
Spinal and Bulbar Muscular Atrophy OverviewKenneth H FischbeckProgress in Neurobiology|June 7, 2012
Developing treatment for spinal and bulbar muscular atrophyKenneth H FischbeckMolecular Therapy. Nucleic Acids|February 12, 2021
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophyAudrey M Winkelsas, Christopher Grunseich, George G Harmison, et al.Trends in Pharmacological Sciences|September 25, 2010
Therapeutic approaches to spinal and bulbar muscular atrophySrikanth Ranganathan, Kenneth H FischbeckJournal of Neurochemistry|February 15, 2020
Combinatorial treatment for spinal muscular atrophy: An Editorial for 'Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells' on page 264Angelo Poletti, Kenneth H FischbeckCurrent Opinion in Neurology|August 11, 2020
Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatmentChristopher Grunseich, Kenneth H FischbeckNeurologic Clinics|October 31, 2015
Spinal and Bulbar Muscular AtrophyChristopher Grunseich, Kenneth H FischbeckHandbook of Clinical Neurology|February 27, 2018
Spinal muscular atrophyEveline S Arnold, Kenneth H FischbeckPageof 13